Jane Street’s Vaxcyte PCVX Stock Holding History

Jane Street’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.2M	Buy	604,900 +31,700	+6%	+$1.72M	﹤0.01%	1664
2026 Q1	$33.3M	Buy	573,200 +544,900	+1,925%	+$29.6M	﹤0.01%	1342
2025 Q4	$1.31M	Buy	28,300 +16,000	+130%	+$716K	﹤0.01%	5598
2025 Q3	$443K	Buy	+12,300	New	+$408K	﹤0.01%	8114
2025 Q2	–	Sell	-8,500	Closed	-$321K	–	10535
2025 Q1	$321K	Sell	8,500 -4,000	-32%	-$320K	﹤0.01%	7690
2024 Q4	$1.02M	Sell	12,500 -9,100	-42%	-$904K	﹤0.01%	5346
2024 Q3	$2.47M	Buy	21,600 +8,600	+66%	+$775K	﹤0.01%	4048
2024 Q2	$982K	Sell	13,000 -3,800	-23%	-$259K	﹤0.01%	5812
2024 Q1	$1.15M	Buy	+16,800	New	+$1.16M	﹤0.01%	5146
2023 Q3	–	Sell	-56,100	Closed	-$2.8M	–	9180
2023 Q2	$2.8M	Buy	+56,100	New	+$2.66M	﹤0.01%	3621

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Jane Street's PCVX Position: Q2 2026 in Review

Jane Street reduced its Vaxcyte (PCVX) stake by 97% in Q2 2026, selling an estimated $13.4M and leaving 6,401 shares worth $372K. The position accounts for ﹤0.01% of the portfolio, ranked #8703.

Jane Street first reported a position in PCVX in Q2 2020 and has held it in 16 quarters since. The position peaked at $24.5M in Q4 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Jane Street held 6,401 shares of Vaxcyte worth $372K as of Q2 2026.
Jane Street sold 246,476 Vaxcyte shares in Q2 2026, an estimated $13.4M.
Vaxcyte made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8703 holding.
Jane Street first reported a position in Vaxcyte in Q2 2020 and has held it in 16 quarters since.
Jane Street's Vaxcyte position peaked at $24.5M in Q4 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.